|
US31617A
(en)
*
|
|
1861-03-05 |
|
photo-uthcqfupheh |
|
US587224A
(en)
*
|
1894-10-10 |
1897-07-27 |
Stewart Dixon Mckelvey |
Head-rest pad
|
|
US3065143A
(en)
*
|
1960-04-19 |
1962-11-20 |
Richardson Merrell Inc |
Sustained release tablet
|
|
US3427378A
(en)
*
|
1965-02-12 |
1969-02-11 |
American Cyanamid Co |
Sustained release encapsulated formula
|
|
GB1093286A
(en)
*
|
1965-02-15 |
1967-11-29 |
Biorex Laboratories Ltd |
Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
|
|
US3555151A
(en)
*
|
1966-12-21 |
1971-01-12 |
Richardson Merrell Inc |
Long acting solid antacid
|
|
US3458622A
(en)
*
|
1967-04-07 |
1969-07-29 |
Squibb & Sons Inc |
Controlled release tablet
|
|
US3574820A
(en)
*
|
1968-01-08 |
1971-04-13 |
Upjohn Co |
Medicinal dosage forms of unpolymerized thiolated gelatin with a cross-linking accelerating agent providing slowly released medication from a swollen matrix
|
|
USRE31617E
(en)
*
|
1972-02-04 |
1984-06-26 |
Bristol-Myers Company |
Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
|
|
US3932407A
(en)
*
|
1973-11-19 |
1976-01-13 |
Bristol-Myers Company |
Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
|
|
US4302386A
(en)
*
|
1978-08-25 |
1981-11-24 |
The Ohio State University |
Antigenic modification of polypeptides
|
|
JPS5512411B2
(enExample)
*
|
1974-03-12 |
1980-04-02 |
|
|
|
US4105776A
(en)
*
|
1976-06-21 |
1978-08-08 |
E. R. Squibb & Sons, Inc. |
Proline derivatives and related compounds
|
|
US4140755A
(en)
*
|
1976-02-13 |
1979-02-20 |
Hoffmann-La Roche Inc. |
Sustained release tablet formulations
|
|
US4123403A
(en)
*
|
1977-06-27 |
1978-10-31 |
The Dow Chemical Company |
Continuous process for preparing aqueous polymer microsuspensions
|
|
US4146718A
(en)
*
|
1978-04-10 |
1979-03-27 |
Bristol-Myers Company |
Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
|
|
US4208521A
(en)
*
|
1978-07-31 |
1980-06-17 |
Bristol-Myers Company |
Process for the preparation of imidazo[2,1-b]quinazolinones
|
|
US4316906A
(en)
*
|
1978-08-11 |
1982-02-23 |
E. R. Squibb & Sons, Inc. |
Mercaptoacyl derivatives of substituted prolines
|
|
IL58849A
(en)
*
|
1978-12-11 |
1983-03-31 |
Merck & Co Inc |
Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
|
|
US4173626A
(en)
*
|
1978-12-11 |
1979-11-06 |
Merck & Co., Inc. |
Sustained release indomethacin
|
|
US4258030A
(en)
*
|
1979-03-07 |
1981-03-24 |
Zeria-Shinyaku Kogyo Kabushiki Kaisha |
Urokinase preparation for oral administration
|
|
US4309405A
(en)
*
|
1979-08-09 |
1982-01-05 |
American Home Products Corporation |
Sustained release pharmaceutical compositions
|
|
US4309404A
(en)
*
|
1979-08-09 |
1982-01-05 |
American Home Products Corporation |
Sustained release pharmaceutical compositions
|
|
US4248857A
(en)
*
|
1979-08-09 |
1981-02-03 |
American Home Products Corporation |
Sustained release pharmaceutical compositions
|
|
US4252786A
(en)
*
|
1979-11-16 |
1981-02-24 |
E. R. Squibb & Sons, Inc. |
Controlled release tablet
|
|
US4508729A
(en)
*
|
1979-12-07 |
1985-04-02 |
Adir |
Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
|
|
US4259314A
(en)
*
|
1979-12-10 |
1981-03-31 |
Hans Lowey |
Method and composition for the preparation of controlled long-acting pharmaceuticals
|
|
US4344949A
(en)
*
|
1980-10-03 |
1982-08-17 |
Warner-Lambert Company |
Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
|
|
ZA817261B
(en)
*
|
1980-10-23 |
1982-09-29 |
Schering Corp |
Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
|
|
US4337201A
(en)
*
|
1980-12-04 |
1982-06-29 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl substituted prolines
|
|
US4444777A
(en)
|
1981-07-30 |
1984-04-24 |
Bristol-Myers Company |
Pharmaceutical compositions of anagrelide and sulfinpyrazone
|
|
US4357330A
(en)
*
|
1981-07-30 |
1982-11-02 |
Bristol-Myers Company |
Pharmaceutical compositions
|
|
US4410520A
(en)
*
|
1981-11-09 |
1983-10-18 |
Ciba-Geigy Corporation |
3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
|
|
GB2128984B
(en)
*
|
1982-05-12 |
1985-05-22 |
Hoffmann La Roche |
Diaza-bicyclic compounds
|
|
US4578079A
(en)
*
|
1982-08-04 |
1986-03-25 |
La Jolla Cancer Research Foundation |
Tetrapeptide
|
|
US4792525A
(en)
*
|
1982-08-04 |
1988-12-20 |
La Jolla Cancer Research Foundation |
Tetrapeptide
|
|
US4614517A
(en)
*
|
1982-08-04 |
1986-09-30 |
La Jolla Cancer Research Foundation |
Tetrapeptide
|
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
|
US4502888A
(en)
*
|
1982-12-13 |
1985-03-05 |
The Dow Chemical Company |
Aqueous dispersions of plasticized polymer particles
|
|
JPS6092299A
(ja)
*
|
1983-10-25 |
1985-05-23 |
Sanwa Kosan Kk |
粉末マルト−スの製造法
|
|
US4568676A
(en)
|
1983-11-25 |
1986-02-04 |
Thomas Jefferson University |
Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
|
|
DE3447669A1
(de)
*
|
1983-12-29 |
1985-07-18 |
Hitachi, Ltd., Tokio/Tokyo |
Verbundstruktur aus metall und kunstharz sowie verfahren zu deren herstellung
|
|
US4780401A
(en)
|
1984-04-09 |
1988-10-25 |
Ciba-Geigy Corporation |
Novel monoclonal antibodies to human renin and hybridoma cells, processes for their preparation and their applications
|
|
US4661471A
(en)
*
|
1984-04-10 |
1987-04-28 |
New England Deaconess Hospital |
Method of inhibiting and inducing human platelet aggregation
|
|
DE3586952T2
(de)
*
|
1985-01-14 |
1993-07-22 |
Shiseido Co Ltd |
Fibrinophiler urokinase-komplex und dessen herstellung.
|
|
IT1191674B
(it)
*
|
1986-03-07 |
1988-03-23 |
Eurand Spa |
Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
|
|
US4816463A
(en)
*
|
1986-04-01 |
1989-03-28 |
Warner-Lambert Company |
Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
|
|
US4756911A
(en)
*
|
1986-04-16 |
1988-07-12 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
US5098840A
(en)
*
|
1986-07-03 |
1992-03-24 |
The Green Cross Corporation |
Human prourokinase mutants
|
|
CA1334092C
(en)
|
1986-07-11 |
1995-01-24 |
David John Carini |
Angiotensin ii receptor blocking imidazoles
|
|
US4772684A
(en)
*
|
1987-01-20 |
1988-09-20 |
Triton Biosciences, Inc. |
Peptides affecting blood pressure regulation
|
|
US5052558A
(en)
*
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US5033252A
(en)
*
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
US5081127A
(en)
*
|
1988-01-07 |
1992-01-14 |
E. I. Du Pont De Nemours And Company |
Substituted 1,2,3-triazole angiotensin II antagonists
|
|
US5446070A
(en)
|
1991-02-27 |
1995-08-29 |
Nover Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
|
US5185323A
(en)
*
|
1988-03-31 |
1993-02-09 |
Temple University |
Suppression of megakaryocytopoiesis employing platelet factor 4 antimaturation factor
|
|
JPH0788352B2
(ja)
*
|
1988-06-16 |
1995-09-27 |
エスエス製薬株式会社 |
ヒドロキシアルキルシステイン誘導体およびこれを含有する去痰剤
|
|
US4847276A
(en)
*
|
1988-09-06 |
1989-07-11 |
Merrell Dow Pharmaceuticals Inc. |
Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione
|
|
GB8903328D0
(en)
*
|
1989-02-14 |
1989-04-05 |
Ethical Pharma Ltd |
Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
|
|
US5064825A
(en)
*
|
1989-06-01 |
1991-11-12 |
Merck & Co., Inc. |
Angiotensin ii antagonists
|
|
US5318899A
(en)
*
|
1989-06-16 |
1994-06-07 |
Cor Therapeutics, Inc. |
Platelet aggregation inhibitors
|
|
US5770564A
(en)
*
|
1989-06-16 |
1998-06-23 |
Cor Therapeutics, Inc. |
Platelet aggregation inhibitors
|
|
US5073566A
(en)
*
|
1989-11-30 |
1991-12-17 |
Eli Lilly And Company |
Angiotensin ii antagonist 1,3-imidazoles and use thereas
|
|
US5091188A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
US5091187A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
US5085992A
(en)
*
|
1990-07-19 |
1992-02-04 |
Merck & Co., Inc. |
Microbial transformation process for antihypertensive products
|
|
US5087634A
(en)
*
|
1990-10-31 |
1992-02-11 |
G. D. Searle & Co. |
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
|
|
US5145684A
(en)
*
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
WO1993009794A1
(en)
*
|
1991-11-15 |
1993-05-27 |
University Of Pennsylvania |
Suppression of megakaryocytopoiesis by neutrophil activating peptide-2
|
|
US5306709A
(en)
*
|
1991-11-15 |
1994-04-26 |
The University Of Pennsylvania |
Suppression of megakaryocytopoiesis by macrophage inflammatory proteins
|
|
US5323907A
(en)
*
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
US5302401A
(en)
*
|
1992-12-09 |
1994-04-12 |
Sterling Winthrop Inc. |
Method to reduce particle size growth during lyophilization
|
|
US5604260A
(en)
*
|
1992-12-11 |
1997-02-18 |
Merck Frosst Canada Inc. |
5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
|
|
US5336507A
(en)
*
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
|
SE9301057L
(sv)
*
|
1993-03-30 |
1994-10-01 |
Pharmacia Ab |
Beredning med kontrollerad frisättning
|
|
US5342626A
(en)
*
|
1993-04-27 |
1994-08-30 |
Merck & Co., Inc. |
Composition and process for gelatin-free soft capsules
|
|
US5474995A
(en)
*
|
1993-06-24 |
1995-12-12 |
Merck Frosst Canada, Inc. |
Phenyl heterocycles as cox-2 inhibitors
|
|
GB9602877D0
(en)
*
|
1996-02-13 |
1996-04-10 |
Merck Frosst Canada Inc |
3,4-Diaryl-2-hydroxy-2,5- dihydrofurans as prodrugs to cox-2 inhibitors
|
|
CN1143365A
(zh)
|
1994-01-10 |
1997-02-19 |
麦克弗罗斯特(加拿大)有限公司 |
作为cox-2抑制剂的苯基杂环类化合物
|
|
US5521213A
(en)
*
|
1994-08-29 |
1996-05-28 |
Merck Frosst Canada, Inc. |
Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
|
|
DE69512930T2
(de)
*
|
1994-10-27 |
2000-05-18 |
Merck Frosst Canada & Co., Halifax |
Stilben-derivate verwendbar als cyclooxygenase-2 hemmer
|
|
US5660854A
(en)
*
|
1994-11-28 |
1997-08-26 |
Haynes; Duncan H |
Drug releasing surgical implant or dressing material
|
|
US5552422A
(en)
*
|
1995-01-11 |
1996-09-03 |
Merck Frosst Canada, Inc. |
Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
|
|
US7070972B1
(en)
*
|
1995-01-13 |
2006-07-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Janus family kinases and identification of immune modulators
|
|
US5871776A
(en)
*
|
1995-01-31 |
1999-02-16 |
Mehta; Atul M. |
Controlled-release nifedipine
|
|
IL112834A
(en)
*
|
1995-03-01 |
2000-12-06 |
Yeda Res & Dev |
Pharmaceutical compositions for controlled release of soluble receptors
|
|
US5612053A
(en)
*
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
|
US5691374A
(en)
*
|
1995-05-18 |
1997-11-25 |
Merck Frosst Canada Inc. |
Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
|
|
US5604253A
(en)
*
|
1995-05-22 |
1997-02-18 |
Merck Frosst Canada, Inc. |
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
|
|
US5639780A
(en)
*
|
1995-05-22 |
1997-06-17 |
Merck Frosst Canada, Inc. |
N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
|
|
US5643933A
(en)
*
|
1995-06-02 |
1997-07-01 |
G. D. Searle & Co. |
Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
|
|
SE9502244D0
(sv)
*
|
1995-06-20 |
1995-06-20 |
Bioglan Ab |
A composition and a process for the preparation thereof
|
|
US5877224A
(en)
*
|
1995-07-28 |
1999-03-02 |
Rutgers, The State University Of New Jersey |
Polymeric drug formulations
|
|
JP3693270B2
(ja)
|
1995-10-12 |
2005-09-07 |
旭化成ケミカルズ株式会社 |
フィルムコーティング顆粒およびその製造方法
|
|
CA2171073A1
(en)
*
|
1995-12-04 |
1997-06-05 |
Philip C. Lang |
Process for the preparation of ethyl-n-(2,3 dichloro-6- nitrobenzyl) glycine
|
|
US5789413A
(en)
*
|
1996-02-01 |
1998-08-04 |
Merck Frosst Canada, Inc. |
Alkylated styrenes as prodrugs to COX-2 inhibitors
|
|
US5733909A
(en)
*
|
1996-02-01 |
1998-03-31 |
Merck Frosst Canada, Inc. |
Diphenyl stilbenes as prodrugs to COX-2 inhibitors
|
|
EP0792647A1
(en)
|
1996-02-27 |
1997-09-03 |
Roche Diagnostics GmbH |
Porphyrins as urokinase-type plasminogen activator receptor antagonists
|
|
US5798246A
(en)
*
|
1996-03-25 |
1998-08-25 |
Incyte Pharmaceuticals, Inc. |
Cyclic nucleotide phosphodiesterase
|
|
GB9607503D0
(en)
*
|
1996-04-11 |
1996-06-12 |
Merck Frosst Canada Inc |
Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors
|
|
US5922742A
(en)
*
|
1996-04-23 |
1999-07-13 |
Merck Frosst Canada |
Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
|
|
US5753702A
(en)
|
1996-05-22 |
1998-05-19 |
University Of Vermont |
Arachidonic acid metabolite, 16-hete
|
|
US6451609B1
(en)
|
1996-05-30 |
2002-09-17 |
The Cleveland Clinic Foundation |
Method of detecting gynecological carcinomas
|
|
US5677318A
(en)
*
|
1996-07-11 |
1997-10-14 |
Merck Frosst Canada, Inc. |
Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents
|
|
US5861419A
(en)
*
|
1996-07-18 |
1999-01-19 |
Merck Frosst Canad, Inc. |
Substituted pyridines as selective cyclooxygenase-2 inhibitors
|
|
WO1998011896A1
(en)
|
1996-09-18 |
1998-03-26 |
Merck & Co., Inc. |
Combination therapy for reducing the risks associated with cardiovascular disease
|
|
US6565858B2
(en)
|
1997-06-03 |
2003-05-20 |
Kureha Chemical Industry Co., Ltd. |
Human ADAMTS-1 protein and pharmaceutical composition
|
|
TR200000272T2
(tr)
*
|
1997-07-31 |
2000-09-21 |
F. Hoffmann -La Roche Ag |
Antitümör ve antimetastaz maddeleri olarak o-ikameli hidrosikumaranon türevleri.
|
|
US6214376B1
(en)
*
|
1998-08-25 |
2001-04-10 |
Banner Pharmacaps, Inc. |
Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
|
|
US6596298B2
(en)
*
|
1998-09-25 |
2003-07-22 |
Warner-Lambert Company |
Fast dissolving orally comsumable films
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
RU2292351C2
(ru)
*
|
1999-03-18 |
2007-01-27 |
Мерк Патент Гмбх |
Полипептид с биологической активностью ингибитора индуцируемой коллагеном адгезии тромбоцитов, его получение и применение
|
|
WO2000064875A1
(en)
*
|
1999-04-23 |
2000-11-02 |
Nippon Shinyaku Co., Ltd. |
Method for pulvirizing to fine powder
|
|
AU7604400A
(en)
*
|
1999-09-21 |
2001-04-24 |
Emory University |
Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
|
|
US20060034937A1
(en)
*
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6627223B2
(en)
*
|
2000-02-11 |
2003-09-30 |
Eurand Pharmaceuticals Ltd. |
Timed pulsatile drug delivery systems
|
|
DE10006286C1
(de)
*
|
2000-02-14 |
2001-10-18 |
3M Espe Ag |
Lichtwellenkonvertervorrichtung und deren Verwendung im Dentalbereich
|
|
NZ522239A
(en)
*
|
2000-04-20 |
2004-03-26 |
Skyepharma Canada Inc |
Improved water-insoluble drug particle process
|
|
KR100392501B1
(ko)
*
|
2000-06-28 |
2003-07-22 |
동국제약 주식회사 |
다중 에멀젼법에 의한 서방출성 미립구의 제조방법
|
|
GB2364714A
(en)
|
2000-07-17 |
2002-02-06 |
British Sugar Plc |
Spray-drying a material in the presence of a particulate solid
|
|
US6388073B1
(en)
|
2000-07-26 |
2002-05-14 |
Shire Us Inc. |
Method for the manufacture of anagrelide
|
|
US20030232389A1
(en)
*
|
2000-08-23 |
2003-12-18 |
Wilhelm Olaf G |
Urokinase peptide structure mimetics
|
|
US6287599B1
(en)
*
|
2000-12-20 |
2001-09-11 |
Shire Laboratories, Inc. |
Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
|
|
US6656493B2
(en)
|
2001-07-30 |
2003-12-02 |
Wm. Wrigley Jr. Company |
Edible film formulations containing maltodextrin
|
|
US6669955B2
(en)
*
|
2001-08-28 |
2003-12-30 |
Longwood Pharmaceutical Research, Inc. |
Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
|
|
US6811794B2
(en)
*
|
2001-12-20 |
2004-11-02 |
Shire Laboratories, Inc. |
Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
|
|
KR100481444B1
(ko)
*
|
2002-03-18 |
2005-04-11 |
원 호 이 |
에너지 절약형 조도 조절기
|
|
WO2003090723A1
(en)
*
|
2002-04-23 |
2003-11-06 |
Bristol-Myers Squibb Company |
Modified-release vasopeptidase inhibitor formulation, combinations and method
|
|
EP1499300B1
(en)
*
|
2002-04-29 |
2009-03-18 |
Supernus Pharmaceuticals, Inc. |
Pharmaceutical formulations with improved bioavailability
|
|
US6735009B2
(en)
|
2002-07-16 |
2004-05-11 |
Motorola, Inc. |
Electroptic device
|
|
JP4133109B2
(ja)
*
|
2002-08-20 |
2008-08-13 |
新キャタピラー三菱株式会社 |
建設機械におけるシャッター式のガード装置
|
|
US7241411B2
(en)
*
|
2002-08-23 |
2007-07-10 |
Acupac Packaging, Inc. |
Thin film strips
|
|
ES2364155T3
(es)
*
|
2002-11-25 |
2011-08-25 |
Jallal Messadek |
Composiciones de betaína y ácido acetilsalicílico.
|
|
US20050214371A1
(en)
*
|
2004-03-03 |
2005-09-29 |
Simona Di Capua |
Stable pharmaceutical composition comprising an acid labile drug
|
|
ES2389047T3
(es)
*
|
2004-04-29 |
2012-10-22 |
Otsuka Pharmaceutical Co., Ltd. |
Anticuerpos específicos contra la glicoproteína VI y procedimientos de producción de estos anticuerpos
|
|
US7700608B2
(en)
*
|
2004-08-04 |
2010-04-20 |
Shire Holdings Ag |
Quinazoline derivatives and their use in the treatment of thrombocythemia
|
|
FR2891459B1
(fr)
*
|
2005-09-30 |
2007-12-28 |
Flamel Technologies Sa |
Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
|
|
CA2631492A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for oral administration
|
|
EA200870217A1
(ru)
|
2006-01-30 |
2009-02-27 |
Экселиксис, Инк. |
4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции
|
|
GB0623750D0
(en)
*
|
2006-11-28 |
2007-01-10 |
Shire Llc |
Substituted quinazolines
|
|
KR100870396B1
(ko)
*
|
2006-12-07 |
2008-11-25 |
보령제약 주식회사 |
심혈관계 질환 치료용 경구투여제제
|
|
BRPI0807807A2
(pt)
*
|
2007-01-25 |
2014-06-17 |
Panacea Biotec Ltd |
" composição farmacêutica de liberação modificada e um processo para fabricar a mesma ".
|
|
ES2538838T3
(es)
|
2007-09-07 |
2015-06-24 |
Mati Therapeutics Inc. |
Método para preparar insertos de fármacos para liberación sostenida de agentes terapéuticos
|
|
GB2462022B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
|